Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Monday, September 12, 2022
Cryoport has entered into a strategic relationship with BioLife Plasma Services, part of the global biopharmaceutical company Takeda, intended to provide consistent, high-quality cellular starting material for use in the manufacture of life-saving ...
read more
Monday, September 12, 2022
WuXi STA, a subsidiary of WuXi AppTec, announced the opening of a new sterile lipid nanoparticle (LNP) formulation development and manufacturing facility at its Wuxi city campus. Created in response to the increasing demand for complex injection ...
read more
Monday, September 12, 2022
KCAS Bioanalytical and Biomarker Services (KCAS), a bioanalytical contract research organization (CRO), backed by Vitruvian Partners, closed the purchase of Active Biomarkers, located in Lyon, France.
read more
Monday, September 12, 2022
AmerisourceBergen Corporation has signed a definitive agreement to acquire PharmaLex Holding GmbH, a leading provider of specialized services for the life sciences industry, from funds advised by AUCTUS Capital Partners AG for €1.28 billion in cash, ...
read more
Monday, September 12, 2022
AiCure, an artificial intelligence (AI) and advanced data analytics has announced the launch of its clinical site services offering. The new program provides sites with end-to-end, customized support and monitoring of metrics related to adherence, ...
read more
Thursday, September 08, 2022
Hovione has expanded its continuous manufacturing offering and services. A new state-of-the-art continuous manufacturing facility is now coming online at the Loures site in Portugal.
read more
Thursday, September 08, 2022
Flagship Biosciences announced the acquisition of Interpace Pharma Solutions ("IPS"), a division of Interpace Biosciences and provider of cytogenetic, molecular pathology, and genomic profiling solutions.
read more
Thursday, September 08, 2022
Aptar Pharma has acquired Metaphase Design Group, a leader in applying the science of human factors engineering and ergonomics to product design.
read more
Thursday, September 08, 2022
Medigen is doubling the amount of space leased at Riverside Technology Park in Frederick, Maryland to 12,000 square feet, which represents the second time the biotech company has expanded its operations at 8420 Gas House Pike within the last 36 ...
read more
Thursday, September 08, 2022
PhoreMost Ltd. has entered into a multi-project target discovery collaboration with Roche. Under the terms of the agreement, PhoreMost will receive an upfront payment and is eligible for preclinical success-based milestones. Further financial terms ...
read more
Thursday, September 08, 2022
Lonza agrees to cooperate with Touchlight to aid in genetic medicine advancement. Through this collaboration, Lonza will have the ability to integrate an additional,
read more
Thursday, September 08, 2022
Univercells Technologies, a provider of novel biomanufacturing technologies for flexible and scalable production of advanced therapies, announced the appointment of Florence Vicaire as Chief Commercial Officer (CCO).
read more
Thursday, September 08, 2022
Cytel expanded its operations into the Asia-Pacific region (APAC). This enables biotech and biopharma companies in APAC to have easier access to Cytel’s established biometrics and advanced statistical solutions.
read more
Wednesday, September 07, 2022
Charles River Laboratories International and Cure AP-4, a non-profit foundation dedicated to raising funds and awareness about Adapter-Protein 4 Hereditary Spastic Paraplegia (AP-4 HSP), have announced a manufacturing collaboration.
read more
Monday, September 05, 2022
Global clinical research services provider CTA Focus has expanded its physical footprint by opening an additional office in North Carolina, USA.
read more